Literature DB >> 2045305

Three-dimensional treatment planning of astrocytomas: a dosimetric study of cerebral irradiation.

A F Thornton1, T J Hegarty, R K Ten Haken, B R Yanke, M L LaVigne, B A Fraass, D L McShan, H S Greenberg.   

Abstract

To demonstrate that 3-dimensional planning is both practical and applicable to the treatment of high-grade astrocytomas, 50 patients over a 2-year period have received cerebral irradiation delivered in focussed, non-axial techniques employing from 2 to 5 beams. Astrocytomas have been planned using rapid, practical incorporation of CT data to define appropriate tumor volumes. Tumor + 3.0 cm and tumor + 1.5 cm volumes have been treated to conventional doses of 4500 cGy and 5940 cGy, respectively, using beam orientations that maximally spared normal remaining parenchyma. Analyses of 3-dimensionally calculated plans have been performed using integral dose-volume histograms (DVH) to help select treatment techniques. Using identical CT-based volumetric data as input for generation of Beam's Eye View (BEV) designed blocks, DVH curves demonstrate dosimetric advantages of non-axial techniques over conventional parallel-opposed orientations. Assessment of the non-axial techniques in selected cases indicates that uniform target volume coverage could be maintained with a typical reduction of 30% in the total amount of brain tissue treated to high dose (95% isodose line).

Entities:  

Mesh:

Year:  1991        PMID: 2045305     DOI: 10.1016/0360-3016(91)90243-w

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  [3-Dimensional irradiation planning in brain tumors. The advantages of the method and the clinical results].

Authors:  A L Grosu; H J Feldmann; C Albrecht; P Kneschaurek; R Wehrmann; M W Gross; F B Zimmermann; M Molls
Journal:  Strahlenther Onkol       Date:  1998-01       Impact factor: 3.621

2.  Bihemispheric malignant glioma: one size does not fit all.

Authors:  G S Bauman; B J Fisher; J G Cairncross; D Macdonald
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

Review 3.  Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy.

Authors:  Silvia Scoccianti; Beatrice Detti; Samantha Cipressi; Alberto Iannalfi; Ciro Franzese; Giampaolo Biti
Journal:  J Neurooncol       Date:  2012-02-18       Impact factor: 4.130

4.  Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03.

Authors:  Christina Tsien; Jennifer Moughan; Jeff M Michalski; Mark R Gilbert; James Purdy; Joseph Simpson; John J Kresel; Walter J Curran; Aidnag Diaz; Minesh P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-23       Impact factor: 7.038

5.  Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme.

Authors:  Lisa B E Shields; Robert Kadner; Todd W Vitaz; Aaron C Spalding
Journal:  Radiat Oncol       Date:  2013-04-25       Impact factor: 3.481

6.  [ (11) C]-methionine positron emission tomography in the postoperative imaging and followup of patients with primary and recurrent gliomas.

Authors:  Matteo Santoni; Cristina Nanni; Alessandro Bittoni; Gabriele Polonara; Alessandro Paccapelo; Roberto Trignani; Mariagrazia De Lisa; Franco Rychlicki; Luciano Burattini; Rossana Berardi; Stefano Fanti; Stefano Cascinu
Journal:  ISRN Oncol       Date:  2014-02-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.